Neurofilament Light Chain as a Potential Marker in Behcet's Disease (NCT06060275) | Clinical Trial Compass
UnknownNot Applicable
Neurofilament Light Chain as a Potential Marker in Behcet's Disease
60 participantsStarted 2024-01-01
Plain-language summary
To determine the role of neurofilament light chain in Behçet's disease with or without neurological affection and its relation to neurological manifestation (either peripheral or central ).
Who can participate
Age range
18 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Exclusion criteria
. Infection (Viral, Bacterial, Fungal)
. Toxic
. Drug induced
. Other diseases (Multiple sclerosis, Neuromyelitis Optica)
. Trauma
. other autoimmune diseases
. Diabetic patients
. purely degenerative diseases
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Since this study is measuring a blood protein called neurofilament light chain in people with Behçet's disease, could my doctor explain whether having neurological symptoms — or being at risk for them — would make my participation in this study more or less relevant to my situation?
2The recruitment status for this trial is listed as unknown, so could my doctor help find out whether this study is still actively enrolling participants or if it has stopped accepting new patients?
3This study involves a blood test to look at neurofilament light chain levels in people with and without nervous system involvement from Behçet's — would my doctor be able to tell me whether my current level of neurological involvement matches what this study is looking for?
4Since this is listed as a non-interventional study focused on measuring a potential marker rather than testing a treatment, could my doctor explain what, if any, direct benefit I might get from participating versus simply continuing my current care?
5Given that Behçet's disease can affect the nervous system in serious ways, could my doctor explain how neurofilament light chain is currently used in other neurological conditions, and whether having my levels measured through this study could tell us anything useful about monitoring my own disease going forward?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
aim at our study to assess the role of NFL chain in serum of behcet disease in those with and without peripheral and central nervous system affection and its relation to neurological manifestation